Lung Transplant Flashcards
BODE Score
Predicts survival in COPD patients.
BMI, airflow Obstruction, Dyspnea and Exercise
CLAD - acronym (in lung transplant)
Chronic lung allograft dysfunction (chronic rejection)
* RAS restrictive allograft syndrome
* BOS bronchiolitis obliterans syndrome
Which virus is PTLPD post transplant lymphoproliferative disease (lymphoma) associated with
EBV
Lung transplant criteria
High (>50%) risk of death due to lung disease within 2 years if lung transplantation is not performed.
High (>80%) likelihood of 5-year post-transplant survival from a general medical perspective provided there is adequate graft function.
Absolute CI lung transplant
- Severely limited functional status with poor rehabilitation potential
- Recent history of malignancy with a high risk of recurrence or death
- Extra pulmonary or disseminated infection or active TB or HIV Infection (detectable viral load)
- Major organ dysfunction
- GFR <40 (unless multi organ transplant)
- Liver cirrhosis or synthetic dysfunction
- Acute coronary syndrome within 30 days
- CVA within 30 days
- Progressive cognitive impairment
- Repeated nonadherence without evidence of improvement (Pediatric patients)
- Active substance use or dependence (tobacco, vaping, marijuana smoking) or IV drug use)
Relative Contraindications for transplant
- Age > 65 with low physiologic reserve
- BMI > 30 (particularly truncal obesity)
- Progressive or severe malnutrition
- Severe, symptomatic osteoporosis.
- Extensive prior chest surgery with lung resection.
- Colonization or infection with highly resistant or highly virulent bacteria, fungi, and certain strains of mycobacteria (chronic extra pulmonary infection expected to worsen after transplantation)
- Hepatitis B and C
- Coronary artery disease
Immunsuppresion regime in lung transplant
- Calcineurine Inhibitors
* Tacrolimus or Cyclosporine
* Require TDM
Cell cycle inhibitors
* Azathioprine of MMF
Prednisone
* Aim for 5-7.5mg daily by 9 months
Common AE of calcineurin inhibitors
renal impairment, hypertension,
hyperglycemia (TAC), hair loss and tremors (Tac)
hirsutism (Cyclosporin),
Common AE with cell cycle inhibitors in lung transplant
Reduced white blood count,
LFT derangement and nausea (AZA),
nausea and diarrhea (MMF)
Antiviral and Antimicrobial prophylaxis in lung transplant
CMV
* For all at risk patients: CMV R+ and CMV R-/D+
* Valganciclovir: myelosuppression, adjust for renal function
EBV
* If not covered by CMV prophylaxis (CMV R-/D-)
* Valacyclovir prophylaxis
* Most at risk EMB R-/D+ (EBV PTLPD)
PCP Prophylaxis
* Cotrimoxazole 480mg thrice weekly (Dapsone 100mg daily if allergic)
CLAD prophylaxis - Chronic lung allograft dysfunction (chronic rejection)
* Azithromycin
Long-term complications of lung transplant
Chronic lung allograft dysfunction (CLAD, chronic rejection)
• Restrictive Allograft Syndrome (RAS)
• Bronchiolitis Obliterans Syndrome (BOS)
* By 5 years 40% will have some degree of allograft dysfunction
Renal Dysfunction
Malignancy
* Skin cancers geography dependent
* Voriconazole can exacerbate the problem
* Reduce immunosuppression